Abstract:OBJECTIVE:To investigate the inhibitory effect of silencing androgen receptor (AR) gene by AR short-hairpin RNA (shRNA) on the growth of human prostate cancer xenograft in nude mice.METHODS:Human 22RV1 prostate cancer cells were inoculated subcutaneously into nude mice to establish xenograft models of human prostate cancer. Meanwhile, a short-hairpin RNA that was capable of suppressing the expression of AR was constructed and then recombinant plasmids producing AR shRNA were prepared in a large number. The tumor-bearing mice were randomly divided into 2 groups: the control group and the experimental group. When the tumor volume grew to about 300 mm(3), the plasmids prepared previously were injected into the tail veins of the mice once at the dose of 2 μg/g in the experimental group, whereas the mice in the control group was injected with the same amount of saline as control. The tumor volumes were monitored every other day until 14 days after the treatment.At the endpoint,the mice were sacrificed and the tumors were excised, weighed, fixed in buffered-formalin, and embedded in paraffin for the immunohistochemical analysis of AR,Ki-67 (a marker of proliferative cell) levels and apoptotic cell labeling by TUNEL (terminal deoxynucleotidyl transterase-mediated dUTP nick end labeling) assay. A semiquantitative immunohistochemical scoring system, HSCORE system, was used to evaluate the expression of AR and proliferative index/Ki-67 labeling index (PI/Ki-67 LI) and apoptotic index (AI) were used to assess the cell proliferation and cell apoptosis, respectively.RESULTS:Compared with the control group, the treatment induced an evident inhibitory effect on the tumor growth in the nude mice with prostate cancer. At the endpoint, the tumor volume of (1 199.56±86.48) mm(3) in the experimental group was significantly smaller than that of (1 742.02±98.16) mm3 in the control group (P=0.002). The tumor weight of (1 006.2±79.1) mg in the experimental group significantly decreased compared with that of (1 383.4±74.8) mg in the control group (P=0.005). The AR HSCORE,PI and AI in the experimental group were 25.8±6.7, (26.0±3.1)%, (55.6±7.9)%, respectively, and those in the control group were 268.8± 18.7, (87.6±7.9)%, (27.2±3.9)%, respectively. There were significant differences between the two groups (all P<0.01).CONCLUSION:AR shRNA could be injected intravenously to suppress the expression of AR in vivo and hence inhibit the growth of human prostate cancer xenograft in nude mice.

Effects of Inhibition of Neural Precursor Cell-Expressed Developmentally Down Regulated 8 Gene on Biological Behavior, and Androgen Receptor of Human Prostate Cancer Cells

The Molecular Mechanisms of Androgen Receptor in Nephrolithiasis.

[Effects of Inhibiting Nucleosomal Binding Protein 1 on Proliferation of Human Prostate Cancer Cells].

[Effects of lncRNA SNHG12 on the proliferation, migration and invasiveness of prostate cancer cells by regulating E2F5 expression]

[Androgen Receptor Silencing by Shrna Inhibits Human Prostate Cancer Xenograft Growth in Nude Mice].

The experimental investigation of androgen-independent prostate cancer cell line inhibited growth in vivo by recombinant lentivirus of small interfering RNA (siRNA) targeting NSBP1

Neddylation Inactivation Represses Androgen Receptor Transcription and Inhibits Growth, Survival and Invasion of Prostate Cancer Cells

The experimental study of short hairpin RNA on the suppression of lung cancer-associated gene

Effect of NUP88 gene on proliferation and invasion biological behavior of breast cancer cell line BT-20

Targeting Silencing Androgen Receptor Gene by Shrna with Low-Intensity Focused Ultrasonic Irradiation Inhibits Growth of Prostate Cancer Xenografts in Nude Mice.

Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.

LINC01207 Promotes the Progression of Non-Small Cell Lung Cancer Via Regulating ARHGAP11A by Sponging Mir-525-5p

Effect of Interleukin-8 Silencing on Androgen-independent Prostate Cancer Stem Cells

Effection of Prostate Cancer Antigen 3(PCA3) on Proliferation of LNCaP Cells

RNA Interference Gene Therapy Targeting NHERF1 Inhibits Proliferation of Prostate Cancer Cell Line PC-3M

Transcriptional suppression of androgen receptor by 18β-glycyrrhetinic acid in LNCaP human prostate cancer cells

The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells

Identification of Androgen Receptor Variant 7-related RNAs Affecting Abiraterone Efficacy in Castration-resistant Prostate Cancer Treatment by RNA-sequencing

Effects of NKX3.1 Gene Knockdown on Gene Expression Profile in LNCaP Cells

The screening of siRNA to AMACR and the influence of LNCaP

NSBP1 regulate the prolifertion and apoptosis of the prostate cancer DU145 cell